Annual EBITDA
$101.95M$436.59M+130.47%
Summary
- Current Value
- As of today, ALVOW annual EBITDA is $101.95M, up +130.47% on
- Historical Performance
- ALVOW annual EBITDA is up +146.08% over the past 3 years, and up +311.89% over the past 5 years
- All-Time High Comparison
- ALVOW annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ALVOW annual EBITDA is +129.84% above its 3-year low of -$341.68M reached on an earlier date
- Sector Comparison
- ALVOW annual EBITDA is higher than 86.39% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $101.95M | +130.5% | +146.1% | +311.9% | +311.9% | |
| Quarterly EBITDA | $184.14M | +13.4% | +297.4% | +369.4% | +369.4% | |
| TTM EBITDA | $171.63M | +312.7% | +210.7% | +351.1% | +351.1% | |
| Price | $0.51 | -84.3% | -66.9% | – | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $489.68M | +435.6% | +1231.7% | +1434.2% | +1434.2% | |
| - | – | – | – | – | ||
| Annual EBIT | -$63.58M | +87.7% | -75.5% | +44.0% | +44.0% | |
| Annual Net Income | -$231.86M | +58.0% | -128.4% | -10.5% | -10.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $101.95M | at high | |
| 5Y | $101.95M | at high | |
| All | $101.95M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$341.68M | N/A | +129.8% |
| 5Y | -$341.68M | +129.8% | |
| All | -$341.68M | +129.8% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $101.95M | +130.5% | |
| -$334.64M | +2.1% | |
| -$341.68M | -54.4% |
| Year | Value | Change |
|---|---|---|
| -$221.25M | -76.1% | |
| -$125.67M | -161.2% | |
| -$48.11M | - |
FAQ
What is the current annual EBITDA of ALVOW?
As of today, ALVOW annual EBITDA is $101.95M
What is 1-year change in ALVOW annual EBITDA?
ALVOW annual EBITDA is up +130.47% year-over-year
What is 3-year change in ALVOW annual EBITDA?
ALVOW annual EBITDA is up +146.08% over the past 3 years
How far is ALVOW annual EBITDA from its all-time high?
ALVOW annual EBITDA is currently at its all-time high
How does ALVOW annual EBITDA rank versus sector peers?
ALVOW annual EBITDA is higher than 86.39% of companies in Healthcare sector
When is ALVOW next annual earnings release?
As of today, the next annual earnings release for ALVOW has not been scheduled
Quarterly EBITDA
$184.14M$285.35M+281.94%
Summary
- Current Value
- As of today, ALVOW quarterly EBITDA is $184.14M, up +281.94% on
- Historical Performance
- ALVOW quarterly EBITDA is up +13.40% year-over-year, and up +297.42% over the past 3 years
- All-Time High Comparison
- ALVOW quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ALVOW quarterly EBITDA is +198.64% above its 3-year low of -$186.67M reached on an earlier date
- Sector Comparison
- ALVOW quarterly EBITDA is higher than 91.30% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $184.14M | +281.9% | +13.4% | +297.4% | +369.4% | |
| Annual EBITDA | $101.95M | – | +130.5% | +146.1% | +311.9% | |
| TTM EBITDA | $171.63M | +14.5% | +312.7% | +210.7% | +351.1% | |
| Price | $0.51 | -68.7% | -84.3% | -66.9% | – | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $113.74M | -34.3% | +10.6% | +497.0% | +10000.0% | |
| - | – | – | – | – | ||
| Quarterly EBIT | $33.29M | -22.3% | -74.4% | +36.2% | +144.3% | |
| Quarterly Net Income | -$5.25M | -116.4% | +53.9% | +38.9% | +93.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $184.14M | at high | |
| 3Y | $184.14M | at high | |
| 5Y | $184.14M | at high | |
| All | $184.14M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$101.21M | +281.9% | |
| 3Y | -$186.67M | N/A | +198.6% |
| 5Y | -$186.67M | +198.6% | |
| All | -$186.67M | +198.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ALVOW?
As of today, ALVOW quarterly EBITDA is $184.14M
What is ALVOW quarterly EBITDA most recent change?
ALVOW quarterly EBITDA was up +281.94% on September 30, 2025
What is 1-year change in ALVOW quarterly EBITDA?
ALVOW quarterly EBITDA is up +13.40% year-over-year
How far is ALVOW quarterly EBITDA from its all-time high?
ALVOW quarterly EBITDA is currently at its all-time high
How does ALVOW quarterly EBITDA rank versus sector peers?
ALVOW quarterly EBITDA is higher than 91.30% of companies in Healthcare sector
When is ALVOW next earnings release?
As of today, the next earnings release for ALVOW has not been scheduled
TTM EBITDA
$171.63M$21.75M+14.51%
Summary
- Current Value
- As of today, ALVOW TTM EBITDA is $171.63M, up +14.51% on
- Historical Performance
- ALVOW TTM EBITDA is up +312.72% year-over-year, and up +210.72% over the past 3 years
- All-Time High Comparison
- ALVOW TTM EBITDA is currently -40.31% below its historical high of $287.54M set on
- 3-Year Low Comparison
- ALVOW TTM EBITDA is +142.43% above its 3-year low of -$404.50M reached on
- Sector Comparison
- ALVOW TTM EBITDA is higher than 85.78% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $171.63M | +14.5% | +312.7% | +210.7% | +351.1% | |
| Annual EBITDA | $101.95M | – | +130.5% | +146.1% | +311.9% | |
| Quarterly EBITDA | $184.14M | +281.9% | +13.4% | +297.4% | +369.4% | |
| Price | $0.51 | -68.7% | -84.3% | -66.9% | – | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $570.95M | +1.9% | +45.7% | +864.9% | +10000.0% | |
| - | – | – | – | – | ||
| TTM EBIT | $76.96M | -55.6% | +135.2% | +155.5% | +202.3% | |
| TTM Net Income | $69.50M | +9.7% | +115.7% | +136.0% | +190.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $287.54M | -40.3% | |
| 3Y | $287.54M | -40.3% | |
| 5Y | $287.54M | -40.3% | |
| All | $287.54M | -40.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $101.95M | N/A | +68.3% |
| 3Y | -$404.50M | +142.4% | |
| 5Y | -$404.50M | +142.4% | |
| All | -$404.50M | +142.4% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ALVOW?
As of today, ALVOW TTM EBITDA is $171.63M
What is ALVOW TTM EBITDA most recent change?
ALVOW TTM EBITDA was up +14.51% on September 30, 2025
What is 1-year change in ALVOW TTM EBITDA?
ALVOW TTM EBITDA is up +312.72% year-over-year
How far is ALVOW TTM EBITDA from its all-time high?
ALVOW TTM EBITDA is currently -40.31% below its historical high of $287.54M set on March 31, 2025
How does ALVOW TTM EBITDA rank versus sector peers?
ALVOW TTM EBITDA is higher than 85.78% of companies in Healthcare sector
When is ALVOW next earnings release?
As of today, the next earnings release for ALVOW has not been scheduled
EBITDA Formula
EBITDA = + + +
Data Sources & References
- ALVOW Official Website www.alvotech.com
- ALVOW Profile on Yahoo Finance finance.yahoo.com/quote/ALVOW
- ALVOW Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/alvow